Papers
5
Total Citations
163
H-Index
5
About
Andreas Hiester is a urologic oncologist whose research has made substantial contributions to the surgical management of testicular germ cell tumors, with a particular focus on retroperitoneal lymph node dissection (RPLND). His work centers on two interconnected themes: refining surgical approaches to RPLND and expanding treatment options for patients with seminomatous testicular cancer. Hiester is perhaps best known for his leadership of the PRIMETEST trial, a prospective phase II study investigating primary RPLND as an alternative to radio- or chemotherapy in stage IIA/B seminoma patients—work that has garnered over 90 citations and represents a landmark effort to reduce treatment-related toxicity without compromising oncological outcomes. Alongside this, he has critically examined minimally invasive and robotic-assisted RPLND techniques, publishing both feasibility analyses and cautionary assessments of unusual recurrence patterns associated with robotic approaches. His 2025 matched-pair analysis further advances the evidence base comparing robot-assisted and open RPLND. Collectively, his portfolio reflects a rigorous, patient-centered approach to a technically demanding field, making his work essential reading for clinicians and researchers navigating the evolving surgical landscape of testicular cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5